© 2026 Alchemist Worldwide Ltd,
All Right Reserved
|
HS Code |
681972 |
| Generic Name | Pertuzumab |
| Brand Name | Perjeta |
| Drug Class | Monoclonal antibody |
| Mechanism Of Action | HER2 receptor antagonist |
| Route Of Administration | Intravenous infusion |
| Primary Indication | HER2-positive breast cancer |
| Molecular Formula | C6428H9956N1714O2018S44 |
| Molecular Weight | 148,058 Daltons |
| Approval Status | FDA approved |
| Initial Approval Year | 2012 |
| Common Side Effects | Diarrhea, alopecia, neutropenia, nausea, fatigue |
| Contraindications | Hypersensitivity to pertuzumab or excipients |
| Manufacturer | Genentech, Inc. |
As an accredited Pertuzumab factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Pertuzumab is supplied in a 20 mL single-use vial containing 420 mg of white to slightly yellow lyophilized powder. |
| Storage | Pertuzumab should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze or shake. Keep the vial in its original packaging to protect it from light. Discard any unused solution if not administered immediately after preparation. Avoid exposure to heat or direct sunlight. Keep out of reach of children and unauthorized personnel. |
| Shipping | Pertuzumab is shipped as a sterile, preservative-free lyophilized powder for intravenous infusion. It must be transported and stored refrigerated at 2–8°C (36–46°F), protected from light, and not frozen. The shipping container should ensure temperature control, stability, and integrity of the product during transit to maintain efficacy and safety. |
Competitive Pertuzumab prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@foods-additive.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@foods-additive.com
